161 related articles for article (PubMed ID: 17976884)
1. Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver.
Cavin C; Marin-Kuan M; Langouët S; Bezençon C; Guignard G; Verguet C; Piguet D; Holzhäuser D; Cornaz R; Schilter B
Food Chem Toxicol; 2008 Apr; 46(4):1239-48. PubMed ID: 17976884
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells.
Cavin C; Mace K; Offord EA; Schilter B
Food Chem Toxicol; 2001 Jun; 39(6):549-56. PubMed ID: 11346484
[TBL] [Abstract][Full Text] [Related]
3. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.
Kwak MK; Itoh K; Yamamoto M; Sutter TR; Kensler TW
Mol Med; 2001 Feb; 7(2):135-45. PubMed ID: 11471548
[TBL] [Abstract][Full Text] [Related]
4. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein.
Higgins LG; Cavin C; Itoh K; Yamamoto M; Hayes JD
Toxicol Appl Pharmacol; 2008 Feb; 226(3):328-37. PubMed ID: 18028974
[TBL] [Abstract][Full Text] [Related]
5. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
[TBL] [Abstract][Full Text] [Related]
6. Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity.
Cavin C; Delatour T; Marin-Kuan M; Holzhäuser D; Higgins L; Bezençon C; Guignard G; Junod S; Richoz-Payot J; Gremaud E; Hayes JD; Nestler S; Mantle P; Schilter B
Toxicol Sci; 2007 Mar; 96(1):30-9. PubMed ID: 17110534
[TBL] [Abstract][Full Text] [Related]
7. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity.
Cavin C; Holzhaeuser D; Scharf G; Constable A; Huber WW; Schilter B
Food Chem Toxicol; 2002 Aug; 40(8):1155-63. PubMed ID: 12067578
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
[TBL] [Abstract][Full Text] [Related]
9. Regulation of glutathione S-transferases and aldehyde reductase by chemoprotectors: studies of mechanisms responsible for inducible resistance to aflatoxin B1.
Hayes JD; McLeod R; Ellis EM; Pulford DJ; Ireland LS; McLellan LI; Judah DJ; Manson MM; Neal GE
IARC Sci Publ; 1996; (139):175-87. PubMed ID: 8923030
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes.
Rubiolo JA; Mithieux G; Vega FV
Eur J Pharmacol; 2008 Sep; 591(1-3):66-72. PubMed ID: 18616940
[TBL] [Abstract][Full Text] [Related]
11. Protection of salvia miltiorrhiza against aflatoxin-B1-induced hepatocarcinogenesis in Fischer 344 rats dual mechanisms involved.
Liu J; Yang CF; Wasser S; Shen HM; Tan CE; Ong CN
Life Sci; 2001 Jun; 69(3):309-26. PubMed ID: 11441922
[TBL] [Abstract][Full Text] [Related]
12. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of coffee against induction of DNA damage and pre-neoplastic foci by aflatoxin B₁.
Ferk F; Huber WW; Grasl-Kraupp B; Speer K; Buchmann S; Bohacek R; Mišík M; Edelbauer L; Knasmüller S
Mol Nutr Food Res; 2014 Feb; 58(2):229-38. PubMed ID: 24039089
[TBL] [Abstract][Full Text] [Related]
14. Potent protective effect of isoimperatorin against aflatoxin B1-inducible cytotoxicity in H4IIE cells: bifunctional effects on glutathione S-transferase and CYP1A.
Pokharel YR; Han EH; Kim JY; Oh SJ; Kim SK; Woo ER; Jeong HG; Kang KW
Carcinogenesis; 2006 Dec; 27(12):2483-90. PubMed ID: 16829687
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver--predicting the outcome using early biomarkers.
Manson MM; Hudson EA; Ball HW; Barrett MC; Clark HL; Judah DJ; Verschoyle RD; Neal GE
Carcinogenesis; 1998 Oct; 19(10):1829-36. PubMed ID: 9806166
[TBL] [Abstract][Full Text] [Related]
16. The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism.
Cavin C; Holzhäuser D; Constable A; Huggett AC; Schilter B
Carcinogenesis; 1998 Aug; 19(8):1369-75. PubMed ID: 9744531
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of phloretin on aflatoxin B1 metabolism: activation and detoxification of aflatoxin B1.
Gao SS; Chen XY; Zhu RZ; Choi BM; Kim SJ; Kim BR
Biofactors; 2012; 38(1):34-43. PubMed ID: 22253071
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the chemopreventive efficacies of garlic powders with different alliin contents against aflatoxin B1 carcinogenicity in rats.
Bergès R; Siess MH; Arnault I; Auger J; Kahane R; Pinnert MF; Vernevaut MF; le Bon AM
Carcinogenesis; 2004 Oct; 25(10):1953-9. PubMed ID: 15180943
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive effects of Furan-2-yl-3-pyridin-2-yl-propenone against 7,12-dimethylbenz[a]anthracene-inducible genotoxicity.
Hwang YP; Han EH; Choi JH; Kim HG; Lee KJ; Jeong TC; Lee ES; Jeong HG
Toxicol Appl Pharmacol; 2008 May; 228(3):343-50. PubMed ID: 18255114
[TBL] [Abstract][Full Text] [Related]
20. Aflatoxin B1 induces apoptosis in rat liver: protective effect of melatonin.
Meki AR; Abdel-Ghaffar SK; El-Gibaly I
Neuro Endocrinol Lett; 2001 Dec; 22(6):417-26. PubMed ID: 11781538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
